356 related articles for article (PubMed ID: 21901234)
21. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
[TBL] [Abstract][Full Text] [Related]
22. Influence of gene polymorphisms in ulcer healing process after superficial venous surgery.
Gemmati D; Tognazzo S; Catozzi L; Federici F; De Palma M; Gianesini S; Scapoli GL; De Mattei M; Liboni A; Zamboni P
J Vasc Surg; 2006 Sep; 44(3):554-62. PubMed ID: 16950433
[TBL] [Abstract][Full Text] [Related]
23. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension.
Gemmati D; Tognazzo S; Serino ML; Fogato L; Carandina S; De Palma M; Izzo M; De Mattei M; Ongaro A; Scapoli GL; Caruso A; Liboni A; Zamboni P
Wound Repair Regen; 2004; 12(5):512-7. PubMed ID: 15453833
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.
Ramacciotti E; Wolosker N; Puech-Leao P; Zeratti EA; Gusson PR; del Giglio A; Franco RF
Thromb Res; 2003 Feb; 109(4):171-4. PubMed ID: 12757770
[TBL] [Abstract][Full Text] [Related]
25. The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion.
Bagheri M; Rad IA; Omrani MD; Nanbaksh F
Syst Biol Reprod Med; 2011 Oct; 57(5):261-4. PubMed ID: 21548851
[TBL] [Abstract][Full Text] [Related]
26. Factor XIII val34leu and the risk of myocardial infarction.
Franco RF; Pazin-Filho A; Tavella MH; Simões MV; Marin-Neto JA; Zago MA
Haematologica; 2000 Jan; 85(1):67-71. PubMed ID: 10629595
[TBL] [Abstract][Full Text] [Related]
27. VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients.
Ferroni P; Palmirotta R; Riondino S; De Marchis ML; Nardecchia A; Formica V; Guadagni F; Roselli M
Thromb Haemost; 2016 Jan; 115(1):143-51. PubMed ID: 26336029
[TBL] [Abstract][Full Text] [Related]
28. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
[TBL] [Abstract][Full Text] [Related]
29. Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis.
Cushman M; Cornell A; Folsom AR; Wang L; Tsai MY; Polak J; Tang Z
Thromb Res; 2007; 121(3):339-45. PubMed ID: 17582472
[TBL] [Abstract][Full Text] [Related]
30. P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.
Ay C; Jungbauer LV; Kaider A; Koder S; Panzer S; Pabinger I; Mannhalter C
Thromb Haemost; 2008 May; 99(5):899-904. PubMed ID: 18449419
[TBL] [Abstract][Full Text] [Related]
31. Thrombin generation as an intermediate phenotype for venous thrombosis.
Segers O; van Oerle Rv; ten Cate Ht; Rosing J; Castoldi E
Thromb Haemost; 2010 Jan; 103(1):114-22. PubMed ID: 20062924
[TBL] [Abstract][Full Text] [Related]
32. [Relationship between fibrinogen B beta gene FGB -455G/A polymorphism and atherosclerotic cerebral infarction].
Sun H; Lu FH; Tian Q; Wen PE; Wu F; Wang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):382-5. PubMed ID: 15300640
[TBL] [Abstract][Full Text] [Related]
33. Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Mezei ZA; Katona É; Kállai J; Bereczky Z; Molnár É; Kovács B; Ajzner É; Bagoly Z; Miklós T; Muszbek L
Thromb Res; 2016 Dec; 148():101-106. PubMed ID: 27821352
[TBL] [Abstract][Full Text] [Related]
34. Factor XIII Val34Leu polymorphism as a modulator of fibrin clot permeability and resistance to lysis in patients with severe coronary artery disease.
Stepień E; Plicner D; Kapelak B; Wypasek E; Sadowski J; Undas A
Kardiol Pol; 2009 Aug; 67(8A):947-55. PubMed ID: 19784898
[TBL] [Abstract][Full Text] [Related]
35. Coagulation factor XIII VaI34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage.
Slowik A; Dziedzic T; Pera J; Figlewicz DA; Szczudlik A
Cerebrovasc Dis; 2005; 19(3):165-70. PubMed ID: 15644629
[TBL] [Abstract][Full Text] [Related]
36. Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.
Dossenbach-Glaninger A; van Trotsenburg M; Oberkanins C; Atamaniuk J
J Clin Lab Anal; 2013 Nov; 27(6):444-9. PubMed ID: 24218126
[TBL] [Abstract][Full Text] [Related]
37. Factor XIII and venous thromboembolism.
Bereczky Z; Muszbek L
Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864
[TBL] [Abstract][Full Text] [Related]
38. The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.
Sucker C; Farokhzad F; Kurschat C; Grabensee B; Scharf RE; Zotz RB; Maruhn-Debowski B; Hetzel GR
Clin Appl Thromb Hemost; 2009; 15(2):197-200. PubMed ID: 17895511
[TBL] [Abstract][Full Text] [Related]
39. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease.
Mills JD; Mansfield MW; Grant PJ
Thromb Haemost; 2002 Mar; 87(3):409-14. PubMed ID: 11916071
[TBL] [Abstract][Full Text] [Related]
40. Activity and levels of factor XIII in a Venezuelan admixed population: association with rs5985 (Val35Leu) and STR F13A01 polymorphisms.
Vívenes M; Castro de Guerra D; Rodríguez-Larralde A; Arocha-Piñango CL; Guerrero B
Thromb Res; 2012 Nov; 130(5):729-34. PubMed ID: 22909824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
